EUCTR2008-003336-38-DK进行中（未招募）不适用
The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in healthy patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy subjects, 18-65 years old, normal body mass index
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known illnesses, substance abuse, pregnancy, a wish not to participate
研究者
相似试验
进行中（未招募）
1 期
The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in patients with hypertension - HASSMedDRA version: 12.1Level: LLTClassification code 10004254Term: Benign essential hypertensionHypertensionEUCTR2010-020599-47-DKDepartments of Medical Research and Medicine25
已完成
不适用
Influence of spironolactone or eplerenone on renin-angiotensin-aldosterone system and left ventricular remodeling after cardiac surgerymyocardial infarction, anginaJPRN-UMIN000001466ihon University School of Medicine300
招募中
不适用
Comparison of spironolactone and amiloride on home blood pressure in resistant hypertensioKCT0004891Yonsei University Health System, Severance Hospital118
已完成
4 期
The Effect of Amiloride and Spironolactone in Patients With HypertensionHypertensionNCT01388088Erling Bjerregaard Pedersen23
已完成
不适用
The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesEssential HypertensionNCT01195805Regional Hospital Holstebro25